Clinical Trial Update: A Mechanistic Study of GSK3228836 With Fine Needle Aspiration (FNA) in Participants With Chronic Hepatitis B [Phase 2]

View source ↗

Summary

Phase 2 mechanistic study evaluating GSK3228836 with fine-needle aspiration in participants with chronic hepatitis B; the trial has completed and results are po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• GSK3228836

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 2 | Status: COMPLETED | Results posted: 2024-12-19